Opinión y propuesta de debate | 26 MAR 20

Altas dosis de Vitamina D, ¿una alternativa en la emergencia?

No suspender el bloqueo del SRAA en la pandemia de COVID-19. Una propuesta de discusión sobre una hipótesis plausible que merece ser analizada ante la urgencia de la pandemia
Autor/a: Dres. Felipe Inserra, Walter Manucha, Carlos Tajer, Leon Ferder Fuente: IntraMed 
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

 

  •  

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. Epub ahead of print.

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72?314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. doi: 10.1001/jama.2020.2648

Sommerstein R, Grani C. Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19. BMJ 2020. https:// www.bmj.com/content/368/bmj.m810/rr-2 (8 March 2020)

Li XC. Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Pharmacol Res. 2017; 125: 21-38

W., Moore, M.J, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. (2003). Angiotensin- converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens T, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten Ch, Pohlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020: 181, 1–10

Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, Widmer AF, Osswal S. SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?. Eur Heart J 2020; online publish-ahead-of-print 18 March 2020

Sun ML, Yang JM, Sun YP, Su GH. [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]., .Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 16;43(0):E014. doi:10.3760/cma.j.issn.1001-0939.2020.0014.

Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res 2020:1-4

  Kuba K, Imai Y, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, LeongPoi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005;436:112–116.

Sodhi CP, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton WB., Wang S, McCray, Jr PB, Chappell M, Hackam DJ, Jia H. Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.Am J Physiol Lung Cell Mol Physiol. 2018; 314: L17–L31. 

Ferder M, Inserra F, Manucha W, Ferder L. The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. Am J Physiol Cell Physiol. 2013;304:C1027-C1039

Colotta F, Jansson B, Bonelli F. Modulation of Inflammatory and Immune Responses by Vitamin D

J Autoimmun. 2017;85:78-97.

Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep 16:7432-7438, 2017

Grant WB., Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States. Dermato-Endocrinology 1:4, 215-219;2009

Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010;91:1255–1260

Gruber-Bzura BM. Vitamin D and In?uenza—Prevention or Therapy? Int J Mol Sci. 2018, 19, 2419-2436

Greiller CL, Martineau R. Modulation of the Immune Response to Respiratory Viruses by Vitamin D. Nutrients 2015, 7, 4240-4270

Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D to prevent exacerbations of COPD:

systematic review and meta-analysis of individual participant data from randomized controlled trials. Thorax: 2019;74:337–345

Rejnmark L, Bislev LS, Cashman KD, Eiri ksdottir G, GakschM, Grubler M, et al. (2017) Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS ONE 12(7):e0180512

Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009; 15: 438–449.

Charan J, Goyal JP, Saxena D, Yadav P. Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis. J Pharmacol Pharmacother 2012; 3: 300–303.

Bergman P, Lindh AU, Bjorkhem-Bergman L, Lindh JD. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE 2013; 8: e65835.

Mao S, Huang S. Vitamin D supplementation and risk of respiratory tract infections: A meta-analysis of randomized controlled trials. Scand J Infect Dis 2013; 45: 696–702.

Das RR, Singh M, Panigrahi I, Naik SS. Vitamin d supplementation for the treatment of acute childhood pneumonia: a systematic review. ISRN Pediatr 2013; 2013: 459160. 215.

Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies. The Journal of Steroid Biochemistry and Molecular Biology 2013; 136: 321–329.

Xiao L, Xing C, Yang Z, Xu S, Wang M, Du H et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. Br J Nutr 2015; 114: 1026–1034.

Yakoob MY, Salam RA, Khan FR, Bhutta ZA. Vitamin D supplementation for preventing infections in children under five years of age. Cochrane Database of Systematic Reviews 2016; CD008824.

Vuichard Gysin D, Dao D, Gysin CM, Lytvyn L, Loeb M. Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE 2016; 11: e0162996.

Giraldo DM, Cardona A, Urcuqui-Inchima S. High-dose of vitamin D supplement is associated with reduced susceptibility of monocyte-derived macrophages to dengue virus infection and proinflammatory cytokine production: An exploratory study. Clin Chim Acta. 2018,478:140-151

Martínez Moreno J, Hernandez JC, Urcuqui Inchima S. Effect of high doses of vitamin D supplementation on dengue virus replication, Toll-like receptor expression, and cytokine profiles on dendritic cells. Mol Cell Bioch 464:169–180; 2020

Bolland M, Grey A, Gamble G, Reid I.  The effect of vitamin D supplementation on skeletal,

vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol

2014; 2: 307–20

Grant, W.B.; Lahore, H.; McDonnell, S.L.; Baggerly, C.A.; French, C.B.; Aliano, J.L.; Bhattoa, H.P. Vitamin D Supplementation Could Prevent and Treat Influenza, Coronavirus, and Pneumonia Infections. Preprints 2020, 2020030235 (doi: 10.20944/preprints202003.0235.v1)

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí